Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MCK

3 Stocks Warren Buffett Just Bought That Deserve a Place in Your Portfolio

The stock market has been under immense pressure since the beginning of the year due to several macroeconomic and geopolitical uncertainties. Amid the current turmoil, renowned investor Warren Buffett's top portfolio holdings may be appealing investments owing to their strong growth potential and ability to endure market headwinds. Recently bought…

StockNews.com

4 Analysts Have This to Say About McKesson

McKesson (NYSE:MCK) has observed the following analyst ratings within the last quarter:

Benzinga

3 Stocks Whose Price Target Were Recently Raised by Wall Street Analysts

The recent market correction caused by surging inflation, the Fed’s hawkish stance, and fears of an economic slowdown have taken a massive toll on investor sentiment. Nevertheless, amid the market downturn, Wall Street Analysts have raised the price targets for McKesson (MCK), GoDaddy (GDDY), and LyondellBasell Industries (LYB). So, let’s…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years

McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 6.7% on an annualized basis producing an average annual return of 17.83%. Currently, McKesson has a market capitalization of $49.19 billion.

Benzinga

Why McKesson Shares Are Jumping Today

McKesson Corp (NYSE:MCK) reported Q4 FY22 adjusted EPS of $5.83, +15% Y/Y, and missing the consensus of $6.04. Revenues increased 12% Y/Y to $66.10 billion, surpassing the consensus of $63.61 billion. U.S. Pharmaceutical segment's Q4 FY22 revenues were $53.67 billion, +14%, driven by an increased volume of specialty products, including higher volumes…

Benzinga

McKesson: Q4 Earnings Insights

McKesson (NYSE:MCK) reported its Q4 earnings results on Thursday, May 5, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings McKesson missed estimated earnings by 3.48%, reporting an EPS of $5.83 versus an estimate of $6.04.

Benzinga

Walgreens Announces $683M Opioid Settlement With Florida

Walgreens Boots Alliance Inc (NASDAQ:WBA) has reached a $683 million settlement with Florida to resolve claims that the pharmacy chain exacerbated an opioid epidemic in the state. The settlement includes $620 million to be paid to Florida over 18 years, plus $63 million for legal fees. The settlement ends a trial that began…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

Benzinga

4 Medical Distributor Stocks That Deserve a Place in Your Portfolio

The rising demand for drugs and other medical products over the past few years has significantly increased the importance of healthcare distributors. Furthermore, the adoption of advanced and emerging technologies in the healthcare supply chain should help the medical distribution market grow robustly. So, we think the shares of fundamentally…

StockNews.com

5 Non-Cyclical Stocks to Buy Now if You're Worried About a Recession

As surging inflation and energy prices foster recessionary fears, it could be wise to bet on non-cyclical stocks because they tend to outperform the broader market when economic growth slows. Given the inelastic demand for their companies’ products, we think the shares of United Parcel Service (UPS), British American Tobacco…

StockNews.com

3 Top-Rated Stocks for Value Investors to Consider

The recent stock market correction has created a few attractive opportunities for investors because many stocks are now trading at reasonable valuations. Thus, it could be wise now to invest in fundamentally solid stocks Bristol-Myers (BMY), McKesson (MCK), and AGCO (AGCO). These names are currently trading at discounts compared to…

StockNews.com

5 No-Brainer Dividend Stocks to Buy for a Recession

Multi-decade high inflation and rising energy prices have stoked recession fears. Therefore, we think investors looking to sidestep a potentially intensifying stock-market downtrend could bet on quality dividend stocks UnitedHealth (UNH), General Dynamics (GD), McKesson (MCK), Waste Connections (WCN), and AmerisourceBergen (ABC). Let’s discuss.

StockNews.com

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

Benzinga

5 Best Healthcare Stocks to Buy as a Hedge Against Inflation

The healthcare sector has historically provided a better hedge against inflation than gold because of the inelastic demand for its products and services. Rising healthcare needs of an aging population, integration of advanced technologies, and breakthroughs in clinical trials brighten the sector’s prospects. Therefore, fundamentally-sound and undervalued healthcare stocks Sanofi…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Stabilize Your Portfolio with These 5 High-Quality Stocks

The stock indices are down, heading for a second straight losing week on investor concerns about geopolitical tensions and the Fed’s actions. And the market is expected to remain volatile in the near term. Hence, we think high-quality stocks Merck & Co. (MRK), Archer-Daniels-Midland (ADM), Baxter (BAX), McKesson (MCK), and…

StockNews.com

Buy These 3 Stable Dividend Stocks to Protect Your Portfolio from Increased Volatility

Soaring inflation, heightened geopolitical tensions, and the Fed’s decision to raise interest rates multiple times this year have fostered severe market volatility of late. So, we think investors looking to protect their portfolios from rising volatility should consider adding quality dividend-paying stocks McKesson (MCK), AmerisourceBergen (ABC), and ORIX (IX) to…

Benzinga

Analyst Ratings For McKesson

McKesson (NYSE:MCK) has observed the following analyst ratings within the last quarter:

Benzinga

McKesson's Return on Invested Capital Insights

Pulled from Benzinga Pro data, McKesson (NYSE:MCK) showed a loss in earnings since Q2, totaling $39.00 million. Sales, on the other hand, increased by 3.06% to $68.61 billion during Q3.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

McKesson Q3 Earnings Beat Street View, Raises FY22 Outlook Boosted By COVID-19 Vaccine Demand

McKesson Corp (NYSE: MCK) reported

Benzinga

Recap: McKesson Q3 Earnings

McKesson (NYSE:MCK) reported its Q3 earnings results on Wednesday, February 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga

McKesson Earnings Preview

McKesson (NYSE:MCK) is set to give its latest quarterly earnings report on Wednesday, 2022-02-02. Here's what investors need to know before the announcement. Analysts estimate that McKesson will likely report an Earnings Per Share (EPS) of $5.42.

1 2 3 4 5

People

Warren Buffett

1,998 stories

Mangeet Kaur BounsMangeet

595 stories

Ashley Moody

109 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Walgreens Boots Alliance

110 stories

108 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.